Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 98 | 2024 | 1030 | 15.870 |
Why?
|
Cannabidiol | 24 | 2024 | 118 | 8.340 |
Why?
|
Anticonvulsants | 54 | 2024 | 1906 | 6.460 |
Why?
|
Epilepsy | 58 | 2024 | 3290 | 5.260 |
Why?
|
Seizures | 36 | 2024 | 2957 | 3.530 |
Why?
|
Epilepsy, Reflex | 6 | 2023 | 25 | 3.450 |
Why?
|
Epilepsies, Myoclonic | 16 | 2024 | 85 | 2.770 |
Why?
|
Angiomyolipoma | 14 | 2021 | 187 | 2.660 |
Why?
|
Epilepsy, Generalized | 9 | 2023 | 178 | 2.560 |
Why?
|
Tumor Suppressor Proteins | 31 | 2021 | 2805 | 2.170 |
Why?
|
Spasms, Infantile | 15 | 2024 | 298 | 2.010 |
Why?
|
Dracunculiasis | 8 | 2024 | 13 | 1.810 |
Why?
|
Dracunculus Nematode | 8 | 2024 | 9 | 1.740 |
Why?
|
Glycemic Index | 6 | 2017 | 396 | 1.530 |
Why?
|
Angelman Syndrome | 6 | 2017 | 140 | 1.500 |
Why?
|
Electroencephalography | 30 | 2023 | 6237 | 1.400 |
Why?
|
Child | 114 | 2024 | 80158 | 1.280 |
Why?
|
Child, Preschool | 81 | 2024 | 42232 | 1.260 |
Why?
|
Fenfluramine | 3 | 2024 | 58 | 1.200 |
Why?
|
Lymphangioleiomyomatosis | 6 | 2021 | 201 | 1.180 |
Why?
|
Helianthus | 2 | 2023 | 11 | 1.080 |
Why?
|
Onchocerciasis | 4 | 2024 | 28 | 1.030 |
Why?
|
Biomphalaria | 4 | 2013 | 23 | 1.010 |
Why?
|
Adolescent | 92 | 2024 | 88326 | 1.000 |
Why?
|
Giant Cell Tumors | 3 | 2021 | 89 | 0.960 |
Why?
|
Ketosis | 5 | 2005 | 46 | 0.940 |
Why?
|
Vigabatrin | 5 | 2012 | 88 | 0.910 |
Why?
|
Onchocerca volvulus | 4 | 2024 | 15 | 0.890 |
Why?
|
Epilepsies, Partial | 6 | 2022 | 431 | 0.880 |
Why?
|
Infant | 54 | 2024 | 36193 | 0.840 |
Why?
|
Schistosoma mansoni | 4 | 2013 | 155 | 0.840 |
Why?
|
Young Adult | 57 | 2024 | 59260 | 0.770 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 641 | 0.760 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2022 | 136 | 0.750 |
Why?
|
Stereotypic Movement Disorder | 1 | 2021 | 30 | 0.740 |
Why?
|
Photosensitivity Disorders | 1 | 2021 | 80 | 0.730 |
Why?
|
Vision, Low | 1 | 2022 | 163 | 0.710 |
Why?
|
Kidney Neoplasms | 10 | 2021 | 4251 | 0.700 |
Why?
|
Humans | 206 | 2024 | 761596 | 0.680 |
Why?
|
Piracetam | 3 | 2009 | 88 | 0.680 |
Why?
|
Diet, Carbohydrate-Restricted | 2 | 2012 | 262 | 0.670 |
Why?
|
Sirolimus | 7 | 2022 | 1533 | 0.670 |
Why?
|
Retrospective Studies | 58 | 2023 | 80647 | 0.640 |
Why?
|
Host-Parasite Interactions | 2 | 2013 | 300 | 0.620 |
Why?
|
Benzodiazepines | 3 | 2018 | 1132 | 0.620 |
Why?
|
Astrocytoma | 6 | 2021 | 775 | 0.620 |
Why?
|
Male | 126 | 2024 | 360846 | 0.610 |
Why?
|
Mosaicism | 5 | 2019 | 475 | 0.610 |
Why?
|
Female | 124 | 2024 | 392705 | 0.600 |
Why?
|
Adult | 92 | 2024 | 221210 | 0.570 |
Why?
|
Treatment Outcome | 35 | 2024 | 64685 | 0.560 |
Why?
|
Epilepsy, Absence | 4 | 2023 | 49 | 0.550 |
Why?
|
Brain | 18 | 2021 | 27121 | 0.530 |
Why?
|
Fructose | 3 | 2010 | 288 | 0.520 |
Why?
|
Ketones | 3 | 2005 | 184 | 0.520 |
Why?
|
Intelligence | 6 | 2012 | 924 | 0.510 |
Why?
|
Food, Formulated | 3 | 2005 | 101 | 0.500 |
Why?
|
Patient Transfer | 1 | 2022 | 794 | 0.500 |
Why?
|
DNA, Helminth | 4 | 2021 | 35 | 0.500 |
Why?
|
Vascular Endothelial Growth Factor D | 2 | 2013 | 64 | 0.490 |
Why?
|
Genetic Variation | 4 | 2018 | 6567 | 0.490 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2015 | 53 | 0.490 |
Why?
|
Neural Plate | 1 | 2014 | 12 | 0.480 |
Why?
|
Photic Stimulation | 1 | 2020 | 1987 | 0.460 |
Why?
|
Disease Transmission, Infectious | 2 | 2019 | 560 | 0.450 |
Why?
|
Myoclonus | 3 | 2023 | 107 | 0.440 |
Why?
|
Ribs | 1 | 2015 | 252 | 0.440 |
Why?
|
Genetics, Population | 1 | 2018 | 937 | 0.440 |
Why?
|
Adjustment Disorders | 1 | 2013 | 67 | 0.440 |
Why?
|
Gene Flow | 1 | 2013 | 78 | 0.430 |
Why?
|
Sturge-Weber Syndrome | 1 | 2014 | 89 | 0.430 |
Why?
|
Arachnoid Cysts | 1 | 2013 | 61 | 0.430 |
Why?
|
Acetamides | 1 | 2015 | 256 | 0.430 |
Why?
|
Bone and Bones | 2 | 2016 | 2568 | 0.420 |
Why?
|
Spasm | 1 | 2013 | 130 | 0.420 |
Why?
|
DNA Mutational Analysis | 8 | 2011 | 4111 | 0.420 |
Why?
|
Phenotype | 10 | 2022 | 16592 | 0.410 |
Why?
|
Middle Aged | 64 | 2024 | 220921 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 24 | 2018 | 36426 | 0.390 |
Why?
|
TOR Serine-Threonine Kinases | 5 | 2020 | 2057 | 0.390 |
Why?
|
Diet Therapy | 3 | 2008 | 151 | 0.390 |
Why?
|
Encephalitis | 2 | 2017 | 440 | 0.380 |
Why?
|
Parent-Child Relations | 4 | 2019 | 761 | 0.380 |
Why?
|
Antibodies, Helminth | 2 | 2024 | 57 | 0.370 |
Why?
|
Syndrome | 5 | 2023 | 3267 | 0.370 |
Why?
|
Lymphedema | 2 | 2015 | 525 | 0.360 |
Why?
|
Age of Onset | 7 | 2020 | 3306 | 0.350 |
Why?
|
Social Adjustment | 1 | 2012 | 632 | 0.350 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5368 | 0.340 |
Why?
|
Child Behavior Disorders | 2 | 2012 | 804 | 0.340 |
Why?
|
Dog Diseases | 3 | 2024 | 141 | 0.330 |
Why?
|
Drug Therapy, Combination | 9 | 2021 | 6312 | 0.330 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2011 | 600 | 0.320 |
Why?
|
Cognition Disorders | 5 | 2011 | 3980 | 0.320 |
Why?
|
Consensus | 5 | 2024 | 3124 | 0.310 |
Why?
|
Vagus Nerve Stimulation | 3 | 2024 | 228 | 0.310 |
Why?
|
Urolithiasis | 1 | 2010 | 125 | 0.310 |
Why?
|
Drugs, Investigational | 1 | 2010 | 212 | 0.310 |
Why?
|
Mutation | 18 | 2020 | 30053 | 0.310 |
Why?
|
Isoxazoles | 1 | 2010 | 232 | 0.310 |
Why?
|
Self Concept | 2 | 2020 | 1045 | 0.310 |
Why?
|
Spine | 1 | 2015 | 1118 | 0.300 |
Why?
|
Pyridoxine | 1 | 2008 | 108 | 0.300 |
Why?
|
Heart Neoplasms | 2 | 2013 | 362 | 0.300 |
Why?
|
Thyroid Nodule | 1 | 2015 | 764 | 0.300 |
Why?
|
Martial Arts | 1 | 2007 | 29 | 0.290 |
Why?
|
Chad | 4 | 2021 | 9 | 0.290 |
Why?
|
Genotype | 13 | 2021 | 12990 | 0.290 |
Why?
|
Blood Glucose | 5 | 2012 | 6391 | 0.290 |
Why?
|
Valproic Acid | 3 | 2009 | 443 | 0.280 |
Why?
|
Ethiopia | 3 | 2018 | 464 | 0.280 |
Why?
|
Pediatrics | 3 | 2012 | 3589 | 0.280 |
Why?
|
Brain Neoplasms | 7 | 2021 | 9032 | 0.270 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2021 | 10766 | 0.270 |
Why?
|
Drug Tolerance | 1 | 2008 | 367 | 0.270 |
Why?
|
Behavioral Symptoms | 1 | 2008 | 186 | 0.270 |
Why?
|
Autistic Disorder | 2 | 2013 | 1220 | 0.270 |
Why?
|
Calcinosis | 3 | 2017 | 1469 | 0.270 |
Why?
|
Mutation, Missense | 2 | 2012 | 2571 | 0.260 |
Why?
|
Vitamin B Complex | 1 | 2008 | 299 | 0.260 |
Why?
|
Quality of Life | 6 | 2021 | 13367 | 0.260 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1625 | 0.260 |
Why?
|
Vagus Nerve | 1 | 2008 | 458 | 0.250 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5779 | 0.240 |
Why?
|
Lipoma | 1 | 2007 | 293 | 0.240 |
Why?
|
Body Height | 1 | 2011 | 1570 | 0.240 |
Why?
|
Hamartoma | 2 | 2022 | 235 | 0.240 |
Why?
|
Psychological Tests | 1 | 2007 | 640 | 0.240 |
Why?
|
Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2024 | 15 | 0.240 |
Why?
|
Dogs | 5 | 2024 | 3839 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 10 | 2018 | 20568 | 0.240 |
Why?
|
Neuropsychological Tests | 7 | 2013 | 7054 | 0.240 |
Why?
|
Genome, Helminth | 2 | 2021 | 15 | 0.230 |
Why?
|
Microsatellite Repeats | 2 | 2018 | 784 | 0.220 |
Why?
|
Cysts | 1 | 2009 | 681 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2529 | 0.220 |
Why?
|
Lateral Ventricles | 1 | 2004 | 146 | 0.220 |
Why?
|
Double-Blind Method | 6 | 2021 | 12341 | 0.220 |
Why?
|
Movement Disorders | 2 | 2023 | 459 | 0.220 |
Why?
|
Cross-Cultural Comparison | 2 | 2019 | 635 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3359 | 0.210 |
Why?
|
Intelligence Tests | 3 | 2011 | 503 | 0.210 |
Why?
|
Mental Disorders | 5 | 2014 | 6845 | 0.210 |
Why?
|
Electric Stimulation Therapy | 1 | 2008 | 628 | 0.200 |
Why?
|
Self-Injurious Behavior | 1 | 2008 | 566 | 0.200 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3713 | 0.190 |
Why?
|
Adaptation, Psychological | 2 | 2011 | 2629 | 0.190 |
Why?
|
Sudan | 2 | 2018 | 86 | 0.190 |
Why?
|
Papio | 2 | 2024 | 669 | 0.190 |
Why?
|
Prostheses and Implants | 1 | 2008 | 1271 | 0.190 |
Why?
|
Angiofibroma | 1 | 2021 | 55 | 0.190 |
Why?
|
Infant, Newborn | 10 | 2024 | 26202 | 0.180 |
Why?
|
Myocardium | 2 | 2013 | 4725 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39106 | 0.180 |
Why?
|
Occipital Lobe | 1 | 2022 | 374 | 0.180 |
Why?
|
Age Factors | 11 | 2016 | 18399 | 0.180 |
Why?
|
Body Weight | 1 | 2011 | 4618 | 0.180 |
Why?
|
Mixed Function Oxygenases | 3 | 1990 | 265 | 0.170 |
Why?
|
Reflex | 1 | 2021 | 376 | 0.170 |
Why?
|
Complementary Therapies | 2 | 2004 | 486 | 0.170 |
Why?
|
Cognition | 3 | 2013 | 6992 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 3 | 2014 | 3165 | 0.170 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2020 | 113 | 0.160 |
Why?
|
Caregivers | 2 | 2023 | 2238 | 0.160 |
Why?
|
Comorbidity | 6 | 2013 | 10508 | 0.160 |
Why?
|
Mali | 1 | 2018 | 50 | 0.160 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 2018 | 49 | 0.160 |
Why?
|
Skin | 3 | 2018 | 4484 | 0.160 |
Why?
|
Schistosomiasis mansoni | 2 | 2011 | 93 | 0.160 |
Why?
|
Endostatins | 1 | 2019 | 168 | 0.160 |
Why?
|
Tumor Burden | 3 | 2020 | 1892 | 0.160 |
Why?
|
Aicardi Syndrome | 1 | 2018 | 16 | 0.150 |
Why?
|
Brain Mapping | 3 | 2010 | 6635 | 0.150 |
Why?
|
Magnetoencephalography | 4 | 2012 | 636 | 0.150 |
Why?
|
Aged | 23 | 2023 | 169310 | 0.150 |
Why?
|
Dietary Fats | 5 | 2006 | 1995 | 0.150 |
Why?
|
Perception | 1 | 2004 | 1197 | 0.150 |
Why?
|
Multienzyme Complexes | 3 | 1990 | 666 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6484 | 0.150 |
Why?
|
Antigens, Helminth | 1 | 2017 | 68 | 0.140 |
Why?
|
Functional Laterality | 4 | 2017 | 2257 | 0.140 |
Why?
|
Animals | 26 | 2024 | 168475 | 0.140 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2024 | 3810 | 0.140 |
Why?
|
Bullying | 1 | 2020 | 232 | 0.140 |
Why?
|
Acidosis | 3 | 2005 | 268 | 0.140 |
Why?
|
Diarrhea | 2 | 2021 | 1318 | 0.140 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4243 | 0.140 |
Why?
|
Chronic Disease | 3 | 2017 | 9319 | 0.140 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 374 | 0.140 |
Why?
|
Family | 1 | 2007 | 3195 | 0.140 |
Why?
|
Eyelids | 3 | 2023 | 278 | 0.140 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2016 | 55 | 0.140 |
Why?
|
Brazil | 2 | 2013 | 1230 | 0.140 |
Why?
|
Cohort Studies | 10 | 2019 | 41495 | 0.140 |
Why?
|
Fibroma | 1 | 2018 | 190 | 0.130 |
Why?
|
Disease Reservoirs | 2 | 2020 | 121 | 0.130 |
Why?
|
Radiography | 3 | 2015 | 6965 | 0.130 |
Why?
|
Acrylic Resins | 1 | 2016 | 135 | 0.130 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14665 | 0.130 |
Why?
|
TRPP Cation Channels | 2 | 2013 | 177 | 0.130 |
Why?
|
Anorexia Nervosa | 1 | 2005 | 1361 | 0.130 |
Why?
|
Mydriasis | 1 | 1995 | 14 | 0.130 |
Why?
|
Sparganosis | 1 | 2015 | 4 | 0.130 |
Why?
|
Spirometra | 1 | 2015 | 4 | 0.130 |
Why?
|
Lymphangiectasis, Intestinal | 1 | 2015 | 10 | 0.130 |
Why?
|
Retinal Diseases | 1 | 2022 | 705 | 0.130 |
Why?
|
bcl-Associated Death Protein | 1 | 2015 | 102 | 0.130 |
Why?
|
Sclerosis | 1 | 2016 | 210 | 0.130 |
Why?
|
Neuroectodermal Tumors | 1 | 2015 | 22 | 0.130 |
Why?
|
Massachusetts | 3 | 2020 | 8833 | 0.130 |
Why?
|
Attitude to Health | 1 | 2004 | 2025 | 0.120 |
Why?
|
Scopolamine | 1 | 1995 | 93 | 0.120 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2015 | 30 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2011 | 592 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2012 | 6019 | 0.120 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2013 | 4575 | 0.120 |
Why?
|
Anthropometry | 2 | 2011 | 1349 | 0.120 |
Why?
|
Internationality | 1 | 2021 | 1001 | 0.120 |
Why?
|
Chi-Square Distribution | 3 | 2012 | 3415 | 0.120 |
Why?
|
Apolipoproteins B | 1 | 2017 | 386 | 0.120 |
Why?
|
Polymerase Chain Reaction | 4 | 2022 | 6075 | 0.120 |
Why?
|
Aged, 80 and over | 10 | 2020 | 58984 | 0.120 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2015 | 144 | 0.120 |
Why?
|
Anesthesia, General | 1 | 2002 | 1174 | 0.120 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4176 | 0.120 |
Why?
|
Prevalence | 7 | 2020 | 15733 | 0.120 |
Why?
|
Gelatin | 1 | 2016 | 220 | 0.120 |
Why?
|
Combined Modality Therapy | 5 | 2010 | 8527 | 0.120 |
Why?
|
Sodium Chloride, Dietary | 1 | 2016 | 293 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4544 | 0.110 |
Why?
|
Ketone Bodies | 2 | 2005 | 76 | 0.110 |
Why?
|
Kidney | 3 | 2016 | 7048 | 0.110 |
Why?
|
Cataract | 1 | 2020 | 832 | 0.110 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8002 | 0.110 |
Why?
|
Intracranial Arterial Diseases | 1 | 2013 | 22 | 0.110 |
Why?
|
Immunoassay | 1 | 2017 | 745 | 0.110 |
Why?
|
Kluver-Bucy Syndrome | 1 | 2013 | 9 | 0.110 |
Why?
|
History, Ancient | 2 | 2005 | 212 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1089 | 0.110 |
Why?
|
Fresh Water | 1 | 2013 | 82 | 0.110 |
Why?
|
Frontal Lobe | 3 | 2013 | 1420 | 0.110 |
Why?
|
Prognosis | 7 | 2020 | 29629 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7391 | 0.110 |
Why?
|
Chagas Disease | 1 | 2015 | 167 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 865 | 0.110 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 2 | 1990 | 61 | 0.110 |
Why?
|
Diagnosis, Differential | 8 | 2018 | 12973 | 0.110 |
Why?
|
Receptors, Nicotinic | 1 | 1996 | 495 | 0.110 |
Why?
|
Trypanosoma cruzi | 1 | 2015 | 206 | 0.110 |
Why?
|
Polycystic Kidney Diseases | 1 | 2013 | 133 | 0.110 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2015 | 412 | 0.100 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7406 | 0.100 |
Why?
|
Introns | 1 | 2015 | 981 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2850 | 0.100 |
Why?
|
Glioma | 1 | 2007 | 3455 | 0.100 |
Why?
|
Neural Stem Cells | 1 | 2020 | 888 | 0.100 |
Why?
|
Competitive Behavior | 1 | 2012 | 78 | 0.100 |
Why?
|
Germ-Line Mutation | 3 | 2020 | 1858 | 0.100 |
Why?
|
Limbic Encephalitis | 1 | 2012 | 36 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 803 | 0.100 |
Why?
|
Body Fat Distribution | 1 | 2013 | 245 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1069 | 0.100 |
Why?
|
Dexamethasone | 4 | 2012 | 1948 | 0.100 |
Why?
|
Neurosurgical Procedures | 3 | 2013 | 2072 | 0.100 |
Why?
|
Abdominal Neoplasms | 1 | 2013 | 287 | 0.100 |
Why?
|
Language Disorders | 1 | 2012 | 140 | 0.100 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2011 | 74 | 0.090 |
Why?
|
Time Factors | 8 | 2016 | 39969 | 0.090 |
Why?
|
Cerebral Arteries | 1 | 2013 | 490 | 0.090 |
Why?
|
Uganda | 1 | 2016 | 1332 | 0.090 |
Why?
|
Genetic Association Studies | 3 | 2017 | 2735 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15843 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2598 | 0.090 |
Why?
|
Microscopy | 1 | 2016 | 903 | 0.090 |
Why?
|
Drug Interactions | 1 | 2015 | 1416 | 0.090 |
Why?
|
Biopsy | 3 | 2018 | 6766 | 0.090 |
Why?
|
Surgical Procedures, Operative | 1 | 2002 | 1924 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 697 | 0.090 |
Why?
|
Metaplasia | 1 | 2011 | 322 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.090 |
Why?
|
Sex Factors | 3 | 2012 | 10554 | 0.090 |
Why?
|
Cerebellum | 1 | 2017 | 1501 | 0.090 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2012 | 173 | 0.090 |
Why?
|
Regression Analysis | 3 | 2017 | 6345 | 0.090 |
Why?
|
Abdomen | 1 | 2016 | 1128 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2872 | 0.080 |
Why?
|
Aging | 4 | 2017 | 8710 | 0.080 |
Why?
|
Risk Factors | 9 | 2019 | 74213 | 0.080 |
Why?
|
Sequence Analysis | 1 | 2010 | 240 | 0.080 |
Why?
|
Longitudinal Studies | 4 | 2017 | 14608 | 0.080 |
Why?
|
Incidence | 5 | 2012 | 21355 | 0.080 |
Why?
|
Sexually Transmitted Diseases | 1 | 2015 | 662 | 0.080 |
Why?
|
Clonazepam | 1 | 2009 | 135 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 1 | 2018 | 1159 | 0.080 |
Why?
|
Epilepsy, Complex Partial | 1 | 2008 | 56 | 0.080 |
Why?
|
Reading | 1 | 2012 | 531 | 0.080 |
Why?
|
Triazines | 2 | 2009 | 311 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1990 | 817 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3688 | 0.080 |
Why?
|
Repressor Proteins | 4 | 2004 | 2986 | 0.080 |
Why?
|
Diet | 2 | 2015 | 8075 | 0.080 |
Why?
|
Online Systems | 1 | 2009 | 182 | 0.080 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1990 | 361 | 0.080 |
Why?
|
Wechsler Scales | 1 | 2008 | 257 | 0.070 |
Why?
|
Social Class | 1 | 2017 | 2004 | 0.070 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2007 | 20 | 0.070 |
Why?
|
Somatostatin | 1 | 1990 | 447 | 0.070 |
Why?
|
Parasite Egg Count | 1 | 2007 | 29 | 0.070 |
Why?
|
Gene Deletion | 2 | 2013 | 2665 | 0.070 |
Why?
|
Respiratory Function Tests | 3 | 2012 | 1682 | 0.070 |
Why?
|
Injections, Intravenous | 2 | 2008 | 1379 | 0.070 |
Why?
|
Developing Countries | 2 | 2017 | 2885 | 0.070 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2013 | 952 | 0.070 |
Why?
|
Exercise | 2 | 2021 | 5890 | 0.070 |
Why?
|
Life Cycle Stages | 1 | 2007 | 160 | 0.070 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2008 | 618 | 0.070 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1418 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2015 | 6214 | 0.070 |
Why?
|
Temporal Lobe | 3 | 2013 | 1695 | 0.070 |
Why?
|
Radiography, Thoracic | 2 | 2012 | 1302 | 0.070 |
Why?
|
Disabled Persons | 1 | 2016 | 1226 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2012 | 4853 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2015 | 6228 | 0.070 |
Why?
|
Electroretinography | 1 | 2008 | 525 | 0.070 |
Why?
|
Drug Resistance | 2 | 2009 | 1596 | 0.070 |
Why?
|
Penetrance | 1 | 2007 | 383 | 0.060 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 470 | 0.060 |
Why?
|
History, 20th Century | 2 | 2005 | 2767 | 0.060 |
Why?
|
Diseases in Twins | 1 | 2007 | 446 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3615 | 0.060 |
Why?
|
Glucose Transporter Type 1 | 1 | 2006 | 186 | 0.060 |
Why?
|
Mexico | 2 | 2020 | 764 | 0.060 |
Why?
|
Psychometrics | 1 | 2015 | 3065 | 0.060 |
Why?
|
History, 17th Century | 1 | 2005 | 108 | 0.060 |
Why?
|
Asia, Central | 1 | 2004 | 13 | 0.060 |
Why?
|
Health Promotion | 1 | 2016 | 2214 | 0.060 |
Why?
|
Compassionate Use Trials | 1 | 2024 | 50 | 0.060 |
Why?
|
History, 18th Century | 1 | 2005 | 207 | 0.060 |
Why?
|
Kidney Diseases | 2 | 2008 | 2091 | 0.060 |
Why?
|
Bicarbonates | 2 | 2002 | 292 | 0.060 |
Why?
|
Pituitary Neoplasms | 2 | 1990 | 1323 | 0.060 |
Why?
|
Acidosis, Lactic | 1 | 2005 | 146 | 0.060 |
Why?
|
Health Surveys | 2 | 2017 | 4061 | 0.060 |
Why?
|
Ivermectin | 1 | 2024 | 46 | 0.060 |
Why?
|
Carcinoma | 1 | 2015 | 2330 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3322 | 0.060 |
Why?
|
Psychology | 1 | 2005 | 356 | 0.060 |
Why?
|
Guatemala | 1 | 2024 | 159 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2017 | 2696 | 0.050 |
Why?
|
Patient Selection | 2 | 2020 | 4244 | 0.050 |
Why?
|
Health Behavior | 1 | 2015 | 2644 | 0.050 |
Why?
|
Protein Kinases | 2 | 2008 | 1608 | 0.050 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13381 | 0.050 |
Why?
|
Language | 1 | 2012 | 1543 | 0.050 |
Why?
|
Autoantibodies | 1 | 2012 | 2118 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2024 | 190 | 0.050 |
Why?
|
Cats | 1 | 2024 | 975 | 0.050 |
Why?
|
Cytochromes b | 1 | 2022 | 35 | 0.050 |
Why?
|
Disease Progression | 2 | 2010 | 13510 | 0.050 |
Why?
|
Liver | 3 | 2017 | 7528 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2400 | 0.050 |
Why?
|
History, 19th Century | 1 | 2005 | 720 | 0.050 |
Why?
|
Parents | 3 | 2020 | 3563 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3052 | 0.050 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2004 | 170 | 0.050 |
Why?
|
Urinary Calculi | 1 | 2002 | 90 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 9001 | 0.050 |
Why?
|
Phytotherapy | 2 | 2014 | 296 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
Expert Testimony | 1 | 2024 | 364 | 0.050 |
Why?
|
Microcephaly | 1 | 2006 | 425 | 0.050 |
Why?
|
Ribosomal Protein S6 Kinases | 3 | 2012 | 203 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5841 | 0.050 |
Why?
|
Observer Variation | 1 | 2007 | 2606 | 0.050 |
Why?
|
Physical Examination | 1 | 2007 | 1255 | 0.050 |
Why?
|
Visual Fields | 1 | 2008 | 1062 | 0.050 |
Why?
|
Genome, Mitochondrial | 1 | 2021 | 66 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15936 | 0.050 |
Why?
|
Plant Extracts | 2 | 2014 | 497 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20100 | 0.040 |
Why?
|
World Health Organization | 2 | 2017 | 1322 | 0.040 |
Why?
|
South Africa | 2 | 2016 | 1843 | 0.040 |
Why?
|
Depression | 1 | 2020 | 8126 | 0.040 |
Why?
|
Heart | 2 | 2013 | 4404 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10774 | 0.040 |
Why?
|
Brain Diseases | 1 | 2009 | 1546 | 0.040 |
Why?
|
Neoplasms | 1 | 2009 | 22173 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15266 | 0.040 |
Why?
|
Pedigree | 1 | 2007 | 4542 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2009 | 1081 | 0.040 |
Why?
|
Epididymis | 2 | 2015 | 228 | 0.040 |
Why?
|
Gene Expression | 2 | 2010 | 7581 | 0.040 |
Why?
|
Immunoblotting | 2 | 2012 | 1646 | 0.040 |
Why?
|
Africa | 1 | 2020 | 709 | 0.040 |
Why?
|
China | 2 | 2015 | 2374 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2020 | 285 | 0.040 |
Why?
|
Pancreatitis | 1 | 2005 | 1096 | 0.040 |
Why?
|
Democratic Republic of the Congo | 1 | 2018 | 86 | 0.040 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 1998 | 68 | 0.040 |
Why?
|
Hydrocephalus | 1 | 2004 | 764 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7828 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 1246 | 0.040 |
Why?
|
Testis | 2 | 2015 | 794 | 0.040 |
Why?
|
Lung | 2 | 2016 | 10002 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 203 | 0.040 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2017 | 13 | 0.040 |
Why?
|
Proteins | 2 | 2004 | 6032 | 0.040 |
Why?
|
Vision Disorders | 1 | 2004 | 1088 | 0.040 |
Why?
|
United States | 6 | 2019 | 72340 | 0.040 |
Why?
|
Prospective Studies | 5 | 2018 | 54423 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4062 | 0.040 |
Why?
|
Prenatal Diagnosis | 1 | 2024 | 1265 | 0.040 |
Why?
|
Trisomy | 1 | 2018 | 260 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2006 | 1509 | 0.030 |
Why?
|
Preoperative Care | 1 | 2006 | 2242 | 0.030 |
Why?
|
Italy | 1 | 2019 | 842 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2005 | 1200 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2791 | 0.030 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.030 |
Why?
|
Disability Evaluation | 2 | 2016 | 1836 | 0.030 |
Why?
|
History, 21st Century | 1 | 2003 | 1567 | 0.030 |
Why?
|
Hypertension | 1 | 2016 | 8540 | 0.030 |
Why?
|
Headache | 1 | 2004 | 1256 | 0.030 |
Why?
|
Interferon-gamma | 2 | 2002 | 3162 | 0.030 |
Why?
|
Torpedo | 1 | 1996 | 170 | 0.030 |
Why?
|
Signal Transduction | 3 | 2020 | 23447 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2024 | 1755 | 0.030 |
Why?
|
Food Parasitology | 1 | 2015 | 6 | 0.030 |
Why?
|
Mice | 7 | 2015 | 81539 | 0.030 |
Why?
|
Hashimoto Disease | 1 | 2017 | 107 | 0.030 |
Why?
|
Research | 1 | 2024 | 1982 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2017 | 523 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4317 | 0.030 |
Why?
|
Marital Status | 1 | 2017 | 426 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 502 | 0.030 |
Why?
|
Patient Compliance | 1 | 2005 | 2690 | 0.030 |
Why?
|
Foodborne Diseases | 1 | 2015 | 41 | 0.030 |
Why?
|
Rett Syndrome | 1 | 2017 | 164 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1250 | 0.030 |
Why?
|
Lethargy | 1 | 2015 | 43 | 0.030 |
Why?
|
Mammals | 1 | 2020 | 1132 | 0.030 |
Why?
|
Nerve Growth Factors | 1 | 1998 | 564 | 0.030 |
Why?
|
Genetic Markers | 1 | 2021 | 2601 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2017 | 957 | 0.030 |
Why?
|
Uniparental Disomy | 1 | 2014 | 45 | 0.030 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2015 | 80 | 0.030 |
Why?
|
Hypernatremia | 1 | 2015 | 78 | 0.030 |
Why?
|
Echoencephalography | 1 | 2015 | 134 | 0.030 |
Why?
|
Diabetes Insipidus | 1 | 2015 | 144 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2005 | 2882 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2015 | 208 | 0.030 |
Why?
|
Self Report | 2 | 2017 | 3725 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 2 | 2012 | 1809 | 0.030 |
Why?
|
Acetylcholine | 1 | 1996 | 629 | 0.030 |
Why?
|
Russia | 1 | 2015 | 384 | 0.030 |
Why?
|
Pilot Projects | 1 | 2007 | 8633 | 0.030 |
Why?
|
Serine | 1 | 1998 | 831 | 0.030 |
Why?
|
Poland | 1 | 2014 | 198 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10212 | 0.030 |
Why?
|
Water Supply | 1 | 2015 | 204 | 0.030 |
Why?
|
Food Contamination | 1 | 2015 | 191 | 0.030 |
Why?
|
Psychotropic Drugs | 1 | 1999 | 888 | 0.030 |
Why?
|
Ghana | 1 | 2015 | 315 | 0.030 |
Why?
|
Species Specificity | 1 | 2018 | 2414 | 0.030 |
Why?
|
Health Services for the Aged | 1 | 2016 | 259 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2015 | 518 | 0.030 |
Why?
|
Puerto Rico | 1 | 2014 | 376 | 0.030 |
Why?
|
Larva | 1 | 2015 | 508 | 0.030 |
Why?
|
Plasma | 1 | 2017 | 586 | 0.030 |
Why?
|
Neurogenesis | 1 | 2020 | 863 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 1995 | 713 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1998 | 823 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2008 | 4481 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11076 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1509 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2010 | 1541 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1749 | 0.020 |
Why?
|
Particle Size | 1 | 2016 | 1648 | 0.020 |
Why?
|
Iopamidol | 1 | 2012 | 186 | 0.020 |
Why?
|
Oral Ulcer | 1 | 2012 | 96 | 0.020 |
Why?
|
Neuromyelitis Optica | 1 | 1996 | 264 | 0.020 |
Why?
|
Sex Distribution | 1 | 2017 | 2280 | 0.020 |
Why?
|
Cannabinoids | 1 | 2014 | 172 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1004 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 1989 | 11904 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2015 | 675 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2008 | 5672 | 0.020 |
Why?
|
Rodent Diseases | 1 | 2011 | 53 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6484 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15502 | 0.020 |
Why?
|
Rats, Inbred Strains | 2 | 1989 | 2088 | 0.020 |
Why?
|
Mutagenesis, Insertional | 2 | 2006 | 656 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3076 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15633 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 702 | 0.020 |
Why?
|
Carboxypeptidase H | 1 | 1990 | 9 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1835 | 0.020 |
Why?
|
Endorphins | 1 | 1990 | 74 | 0.020 |
Why?
|
Bucladesine | 1 | 1989 | 118 | 0.020 |
Why?
|
Stomatitis | 1 | 2012 | 271 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2707 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1552 | 0.020 |
Why?
|
Carboxypeptidases | 1 | 1990 | 154 | 0.020 |
Why?
|
Cycloheximide | 1 | 1989 | 343 | 0.020 |
Why?
|
Educational Status | 1 | 2017 | 2522 | 0.020 |
Why?
|
Hyperplasia | 1 | 2012 | 1152 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2122 | 0.020 |
Why?
|
Hypotension | 1 | 2015 | 879 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 694 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2112 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2510 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 3025 | 0.020 |
Why?
|
Peptide Biosynthesis | 1 | 1987 | 52 | 0.020 |
Why?
|
India | 1 | 2015 | 2348 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1860 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 1739 | 0.020 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2012 | 389 | 0.020 |
Why?
|
Enzyme Precursors | 1 | 1987 | 170 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 1995 | 2693 | 0.020 |
Why?
|
Ultrasonography | 2 | 2011 | 5971 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2217 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1869 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1530 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1432 | 0.020 |
Why?
|
Athetosis | 1 | 2006 | 15 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1230 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1551 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2004 | 9280 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1120 | 0.020 |
Why?
|
Genes | 1 | 1989 | 1823 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1989 | 1463 | 0.020 |
Why?
|
Exons | 2 | 2002 | 2391 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1990 | 951 | 0.020 |
Why?
|
Chorea | 1 | 2006 | 79 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1222 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2014 | 2421 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26129 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2004 | 3597 | 0.020 |
Why?
|
Hematoma | 1 | 1990 | 767 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1899 | 0.020 |
Why?
|
Amides | 1 | 1987 | 449 | 0.020 |
Why?
|
Fever | 1 | 2012 | 1618 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1990 | 1626 | 0.020 |
Why?
|
Organ Specificity | 1 | 1989 | 1968 | 0.010 |
Why?
|
RNA, Messenger | 2 | 1990 | 12794 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5774 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 2006 | 439 | 0.010 |
Why?
|
Alcoholism | 1 | 2015 | 1973 | 0.010 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2004 | 92 | 0.010 |
Why?
|
Pregnancy | 2 | 2024 | 29890 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4077 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 1971 | 1027 | 0.010 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1985 | 362 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 1702 | 0.010 |
Why?
|
Heart Atria | 1 | 1989 | 1345 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4281 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9610 | 0.010 |
Why?
|
Pituitary Gland | 1 | 1985 | 635 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2192 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3537 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 473 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1496 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2004 | 332 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 477 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1990 | 6131 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4016 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1990 | 1974 | 0.010 |
Why?
|
Liver Diseases | 1 | 1990 | 1297 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 641 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1998 | 10194 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 1998 | 7593 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1911 | 0.010 |
Why?
|
Isoenzymes | 1 | 1985 | 1687 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 1 | 2000 | 110 | 0.010 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2001 | 91 | 0.010 |
Why?
|
Rats | 3 | 1998 | 23741 | 0.010 |
Why?
|
Phosphorylation | 2 | 2004 | 8321 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4948 | 0.010 |
Why?
|
RNA | 1 | 1989 | 2725 | 0.010 |
Why?
|
Gene Duplication | 1 | 2000 | 314 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5307 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7968 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9053 | 0.010 |
Why?
|
PC12 Cells | 1 | 1998 | 317 | 0.010 |
Why?
|
Carbamazepine | 1 | 1998 | 224 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2820 | 0.010 |
Why?
|
Genes, Immediate-Early | 1 | 1998 | 102 | 0.010 |
Why?
|
Herpesvirus 3, Human | 1 | 1998 | 159 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2002 | 1998 | 0.010 |
Why?
|
Patient Care Team | 1 | 2008 | 2521 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1998 | 255 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2112 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2000 | 1494 | 0.010 |
Why?
|
Emotions | 1 | 2008 | 2739 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1130 | 0.010 |
Why?
|
Herpes Zoster | 1 | 1998 | 253 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 1998 | 352 | 0.010 |
Why?
|
Haplotypes | 1 | 2002 | 2713 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1998 | 618 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2008 | 3415 | 0.010 |
Why?
|
Cell Line | 1 | 1989 | 15601 | 0.010 |
Why?
|
Gene Frequency | 1 | 2002 | 3606 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2004 | 2457 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 687 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2004 | 2448 | 0.010 |
Why?
|
Interleukin-4 | 1 | 1998 | 1149 | 0.010 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 1996 | 253 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2425 | 0.010 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 1996 | 246 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1989 | 18966 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17635 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12947 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22174 | 0.010 |
Why?
|
Epitopes | 1 | 1998 | 2503 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 14033 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1998 | 1889 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18255 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4514 | 0.010 |
Why?
|
Alleles | 1 | 2002 | 6864 | 0.010 |
Why?
|
Autoimmunity | 1 | 1998 | 1356 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13642 | 0.000 |
Why?
|
Parity | 1 | 1971 | 927 | 0.000 |
Why?
|
Spirometry | 1 | 1971 | 929 | 0.000 |
Why?
|
Administration, Oral | 1 | 1996 | 4021 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1998 | 3156 | 0.000 |
Why?
|
Pulmonary Emphysema | 1 | 1971 | 684 | 0.000 |
Why?
|
Blotting, Northern | 1 | 1987 | 1545 | 0.000 |
Why?
|
Hypophysectomy | 1 | 1985 | 114 | 0.000 |
Why?
|
Captopril | 1 | 1985 | 265 | 0.000 |
Why?
|
Employment | 1 | 1971 | 1118 | 0.000 |
Why?
|
Autoradiography | 1 | 1985 | 728 | 0.000 |
Why?
|
Histocytochemistry | 1 | 1985 | 698 | 0.000 |
Why?
|
Antibody Formation | 1 | 1987 | 1395 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1987 | 4174 | 0.000 |
Why?
|
Cattle | 1 | 1987 | 3849 | 0.000 |
Why?
|
Pain Measurement | 1 | 1990 | 3551 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1987 | 3733 | 0.000 |
Why?
|
Heart Diseases | 1 | 1971 | 2781 | 0.000 |
Why?
|
Base Sequence | 1 | 1987 | 12441 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1987 | 13446 | 0.000 |
Why?
|
DNA | 1 | 1987 | 7213 | 0.000 |
Why?
|
Bronchospirometry | 1 | 1971 | 10 | 0.000 |
Why?
|
Heart Function Tests | 1 | 1971 | 318 | 0.000 |
Why?
|